Skip to content
Governance Register

← US public companies

Iteos Therapeutics, Inc.

SEC CIK 1808865 · ITOS · last insider filing 2025-08-29

Directors (from insider filings)

NameCapacity as filedFilings
Rhoads ANN D Director filed 2020 - 2025
Hallal David Director filed 2020 - 2025
Detheux Michel Director · Chief Executive Officer filed 2020 - 2025
Lee David K Director filed 2023 - 2025
Gadicke Ansbert Director filed 2020 - 2025
Van Hauwermeiren Timothy Director filed 2020 - 2025
Davis Aaron I. Director filed 2020 - 2024
Ho Tony W Director filed 2021 - 2024
Iannone Robert Director filed 2021 - 2024
Desimone Jill Director filed 2024 - 2024
RA Capital Healthcare Fund LP Director filed 2021 - 2024
RA Capital Management, LLC Director filed 2020 - 2024
Kolchinsky Peter Director filed 2020 - 2024
Boxer Capital, LLC Director filed 2020 - 2024
Shah Rajeev M. Director filed 2020 - 2024
Dirocco Derek Director filed 2020 - 2023
Biniszkiewicz Detlev Director filed 2020 - 2022
Roden Matthew Director filed 2020 - 2022
Belawat Priyanka Director filed 2020 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Gall Matthew Chief Financial Officer filed 2020 - 2025
Call Matthew Chief Operating Officer filed 2020 - 2025
Mcgrath Yvonne VP, Research and Development filed 2020 - 2025
Feltquate David Chief Medical Officer filed 2024 - 2025
Lager Joanne Jenkins Chief Medical Officer filed 2020 - 2023

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.